About WORLD MENTAL HEALTH 2024
The 35th International Conference on Public Mental Health and Neurosciences, held in Paris, France on November 18-19, 2024, focuses on advancing mental health and neuroscience through interdisciplinary collaboration. Explore the latest research, policy insights, and practical strategies to promote mental well-being and address neurological disorders globally. Join experts, practitioners, and advocates in bridging the gap between science, policy, and practice for a healthier, more resilient society. the theme of “Advancing Mental Health & Neurosciences: Science, Policy, Practice”
Sessions & Tracks
This track likely focuses on the intersection of mental health conditions and the healthcare system. It may cover topics such as access to mental health services, treatment modalities, stigma reduction, and policy implications for mental healthcare.
-
Mental illness
-
healthcare access
-
stigma
-
treatment modalities
-
policy
-
psychiatric care
-
patient advocacy
This track is likely centered around the development and application of therapeutic interventions for neurological disorders. It may encompass various treatment modalities such as pharmacological treatments, neuromodulation techniques, and emerging therapies targeting the nervous system.
-
Neurological disorders
-
therapeutic interventions
-
pharmacotherapy
-
neuromodulation
-
neuroplasticity
-
neurorehabilitation
-
neuropharmacology
Market Analysis
WORLD MENTAL HEALTH 2024 disorders are prevalent conditions affecting individuals worldwide, stemming from a combination of genetic and environmental factors that disrupt emotional and behavioral equilibrium. While behavioral and psychotherapies are primary treatments, medications are sometimes prescribed alongside them. The Mental Health market encompasses drugs targeting a spectrum of disorders, including depressive, anxiety, sleeping, and psychotic disorders.
Projections indicate that by 2024, the Mental Health market will reach a revenue of US$38.42 billion, with an expected annual growth rate (CAGR 2024-2028) of 0.67%, culminating in a market volume of US$39.46 billion by 2028. Notably, the United States is anticipated to generate the highest revenue, projected at US$11,730.00 million in 2024. On a per capita basis, each individual contributes approximately US$66.31 to the market's revenue in 2024.